We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
COVID-19 Vaccines: Special Considerations for the Obese Population.
- Authors
Kipshidze, Nicholas; Kipshidze, Nodar; Fried, Martin
- Abstract
Current COVID-19 vaccine trials have shown no difference in the vaccine efficacy between normal and obese BMI groups. Given the negative effects of obesity on the immune system and possible implications in uptake of vaccines, effective and minimally invasive weight loss therapies are needed. The utilization of these therapies could offer effective (even if limited for a few years) weight loss with a possibly positive impact on lowering the prevalence of serious COVID-19 and enhancing immunogenicity of SARS-CoV-2 vaccines in otherwise compromised obese patients. While BMI was correlated with a higher initial increase in IgG antibodies post-immunization, at 12 months post-vaccination, higher BMI was associated with a greater decline in antibody titers [[11]].
- Subjects
COVID-19 vaccines; MORBID obesity; OBESITY; MEDICAL students; IMMUNIZATION of children; FLU vaccine efficacy; WEIGHT loss; AMBULATORY surgery
- Publication
Obesity Surgery, 2021, Vol 31, Issue 8, p3854
- ISSN
0960-8923
- Publication type
Letter
- DOI
10.1007/s11695-021-05404-y